MPOWERHealth, a leading innovator in the field of intraoperative neuromonitoring (IONM), has made a significant move to expand its services through the strategic acquisition of Assure Neuromonitoring’s operations in critical markets. This pivotal step not only broadens MPOWERHealth’s patient coverage to an impressive annual count of over 55,000 but also reinforces its position as a […]
In a strategic move to revolutionize cancer treatment, AstraZeneca has announced its definitive agreement to acquire Fusion Pharmaceuticals Inc., a pioneer in the development of next-generation radioconjugates (RCs) for cancer therapy. This acquisition is a pivotal step for AstraZeneca in fulfilling its vision to transform cancer care, aiming to substitute conventional treatments such as chemotherapy […]
Lunit (KRX:328130.KQ), a frontrunner in AI-powered solutions for cancer diagnostics and therapeutics, is marking a significant milestone in its expansion across Europe through two pivotal commercial agreements. The company has secured supply contracts with TeleDiag, the leading teleradiology group in France, and the central region branch of the Portuguese League Against Cancer (LPCC), signifying a […]
The Kroger Co. (NYSE: KR) has announced a definitive agreement for the sale of its specialty pharmacy business to CarelonRx, a subsidiary of Elevance Health, marking a significant transaction in the healthcare industry. The deal is poised to reshape Kroger’s involvement in specialty pharmacy services, underscoring the company’s strategic evaluation of its assets to enhance […]
Microsoft Corp. is expanding its longstanding partnership with NVIDIA, setting a new benchmark in the integration of generative AI, cloud, and accelerated computing within the healthcare and life sciences sectors. This collaboration converges Microsoft Azure’s global scale, security, and advanced computing prowess with NVIDIA’s DGX Cloud and the comprehensive NVIDIA Clara computing platforms, software, and […]
In a significant development in the healthcare industry, Bristol Myers Squibb (NYSE: BMY) and 2seventy bio, Inc. (Nasdaq: TSVT) have announced a favorable vote by the U.S. Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) regarding Abecma (idecabtagene vicleucel). The committee’s 8-3 vote supports the therapy’s benefit/risk profile for patients with triple-class exposed […]
In a notable development for the pharmaceutical industry, Zydus Lifesciences Limited, along with its subsidiaries and affiliates, has received final approval from the United States Food and Drug Administration (USFDA) for the manufacture and market of Chlorpromazine Hydrochloride Injection USP. The approval encompasses two formulations: 25 mg/mL and 50 mg/2 mL (25 mg/mL) in Single-Dose […]
In a significant announcement at the US Biophysical Society in Philadelphia, Asep Medical Holdings Inc. (CSE: ASEP) (OTCQB: SEPSF) (FSE: JJ8) has shared a breakthrough in the battle against antibiotic resistance and biofilm infections. Dr. Bob Hancock, CEO of Asep Inc., detailed how the company is leveraging artificial intelligence (AI) to develop new, more effective […]
Microba Life Sciences Limited (ASX: MAP) has officially launched the MetaPanel product to healthcare professionals on Wednesday, 13 March 2024. This innovative product marks a significant milestone in the collaboration between Microba and Sonic Healthcare Limited (ASX: SHL) through its wholly-owned subsidiary, Douglass Hanly Moir Pathology Pty Ltd, aimed at distributing the advanced gastrointestinal pathogen […]
Royal Philips, a global leader in health technology, announced a significant milestone at India Live 2024 in New Delhi: the completion of over 1500 Cath Lab (interventional suite) installations across the Indian Subcontinent. This achievement underscores Philips’ commitment to enhancing healthcare through innovative solutions, aligning with the company’s Quadruple Aim: improving health outcomes, patient and […]